Esperion Therapeutics, Inc. is an American biopharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative therapies to lower cholesterol and prevent cardiovascular disease. The company primarily targets patients who are unable to achieve their cholesterol goals with commonly available statins, offering alternative treatment options aimed at improving quality of life and reducing the risk of cardiac events.